Rep. Pallone’s Energy And Commerce Win Is Salve For Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
Anna Eshoo, who championed the brand-friendly biosimilars pathway, had challenged Pallone for ranking member post in House Energy and Commerce Committee.
You may also be interested in...
Waxman’s Congressional Exclusivity Set To Expire, But There Will Be No Equivalents
Retiring after 40 years in Congress, Waxman leaves an enormous legacy, but also many recent legislative defeats.
Follow-On Biologics: Defeat For Waxman, Win For Health Reform
Lopsided committee vote suggests that lengthy exclusivity is here to stay, which means that big pharma can get more comfortably behind the broader reform effort.
Pink Sheet Podcast: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
Pink Sheet reporters and editor discuss the upcoming US Supreme Court arguments on mifepristone access, the SCOTUS reaction to the fight against misinformation, and the FDA’s Oncologic Drugs Advisory Committee going against three negative product reviews.